APA (7th ed.) Citation

H, H., J, D., J, M., A, L., RJ, L., & GM, T. (2025). IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models. Molecular cancer therapeutics, 24(12), 1845. https://doi.org/10.1158/1535-7163.MCT-25-0484

Chicago Style (17th ed.) Citation

H, Huang, Deckert J, Mysliwy J, Lodge A, Lutz RJ, and Thurber GM. "IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models." Molecular Cancer Therapeutics 24, no. 12 (2025): 1845. https://doi.org/10.1158/1535-7163.MCT-25-0484.

MLA (9th ed.) Citation

H, Huang, et al. "IKS04, a CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models." Molecular Cancer Therapeutics, vol. 24, no. 12, 2025, p. 1845, https://doi.org/10.1158/1535-7163.MCT-25-0484.